Celularity Inc. CELU
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -66.34% | -77.37% | -43.16% | -52.64% | -22.17% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -66.34% | -77.37% | -43.16% | -52.64% | -22.17% |
| Cost of Revenue | -59.14% | 0.42% | 0.54% | 146.91% | 116.71% |
| Gross Profit | -69.59% | -130.31% | -74.51% | -95.05% | -39.64% |
| SG&A Expenses | -35.74% | -6.19% | -26.43% | -20.58% | 1.67% |
| Depreciation & Amortization | 0.00% | -494.41% | -13.33% | -18.42% | -32.60% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -36.20% | -11.97% | -12.92% | -3.08% | -0.66% |
| Operating Income | 3.37% | -113.22% | -11.47% | -55.91% | -42.16% |
| Income Before Tax | 104.42% | -83.25% | -43.35% | -277.99% | 10.26% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 104.42% | -83.27% | -43.35% | -277.99% | 10.26% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 104.42% | -83.27% | -43.35% | -277.99% | 10.26% |
| EBIT | 3.37% | -113.22% | -11.47% | -55.91% | -42.16% |
| EBITDA | 1.34% | -148.15% | -14.98% | -71.54% | -65.75% |
| EPS Basic | 102.75% | -44.07% | -19.56% | -243.89% | 17.97% |
| Normalized Basic EPS | 106.02% | -10.08% | -22.60% | -232.12% | 29.82% |
| EPS Diluted | 102.37% | -44.07% | -19.56% | -243.89% | 17.97% |
| Normalized Diluted EPS | 105.78% | -10.08% | -22.60% | -232.12% | 29.82% |
| Average Basic Shares Outstanding | 23.53% | 27.64% | 19.89% | 9.93% | 9.75% |
| Average Diluted Shares Outstanding | 28.77% | 27.64% | 19.89% | 9.93% | 9.75% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |